I25
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - symptomatic CAD (coronary artery disease) - CCS >=2 (Canadian Cardiovascular Society) - AP-frequency >=2/week - German-speaking
Exclusion criteria
Exclusion criteria: - EF <35% (ejection fraction) - severe pulmonary disease - impaired vision - impaired hearing - dementia - drugs with influence on the opiod system - high grade valve impairment - Hb <=7 mg/dL - participation in other interventional clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Seattle Angina Questionnaire (SAQ) derived Quality of life score is assessed during the hospital stay of the angioplasty. This is repeated after 1 and 6 months in a phone interview. Primary endpoint of this study is the change in the quality of life as it is meassured in the Seattle Angina Questionnaire one and six months after stent implantation. This questionnaire is filled out by the study doctor together with the patient during the initiatl hospital stay. The follow up after 1 and 6 months is performed in a telephone interview. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are changes in the other derived SAQ-Scores (physical limitation, angina stability, Angina frequency, treatment satisfaction, disease perception) and the dyspnea (NYHA Score) after 1 and 6 months compared to the intial assessment during the initial hospital stay. | — |
Countries
Germany
Contacts
Universistätsklinikum Regensburg